Oncobiology Symposium
ISSN: 2966-4438
Papers (5)
-
Development of new combination strategies for fist-line chemotherapy with selective cyclin-dependent kinases (CDK) 4/6 inhibitors in colorectal cancer and glioblastoma
Vol 1, 2020 -131595 -
DEVELOPMENT OF NEW COMBINATION STRATEGIES FOR FIRST-LINE CHEMOTHERAPY WITH SELECTIVE CYCLIN-DEPENDENT KINASES (CDK) 4/6 INHIBITORS IN COLORECTAL CANCER
Vol 2, 2021 -142446 -
DEVELOPMENT OF NEW COMBINATION STRATEGIES OF CHEMOTHERAPY WITH SELECTIVE CYCLIN-DEPENDENT KINASES (CDK) 4/6 INHIBITORS IN COLORECTAL CANCER
Vol 3, 2022 -155233 -
DEVELOPMENT OF STRATEGIES FOR TREATMENT OF CHEMOTHERAPY COMBINED WITH SELECTIVE CYCLIN-DEPENDENT KINASES (CDK) 4/6 INHIBITORS IN COLORECTAL CANCER
-167161 -
THE ROLE OF TUMOR SUPPRESSOR P53 IN THE INTERACTION BETWEEN ASTROCYTES AND GLIOBLASTOMA CELLS
-167222
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
